GlassScriptPhysician profile
Diane Peterman
NPI 1740310044
$816.65
in general payments reported to CMS, 2019-2025
19 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $74.92 · 2024: $598 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $178.49 | 2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Dexcom, INC. | $110.22 | 2024-2025 | Dexcom G6 Transmitter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $106.16 | 2023-2024 | Lifevest |
| Merck Sharp & Dohme LLC | $55.28 | 2024 | Verquvo |
| Mylan Specialty L.P. | $48.70 | 2024 | Yupelri |
| Esperion Therapeutics, INC. | $39.79 | 2024-2025 | Nexletol |
| Inari Medical, INC. | $38.83 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lilly USA, LLC | $36.40 | 2025 | Mounjaro, Zepbound |
| Viatris Specialty LLC | $25.31 | 2025 | Yupelri |
| Cvrx, INC. | $23.74 | 2024 | Barostim Neo System |
| Inspire Medical Systems, INC. | $23.55 | 2024 | Inspire |
| Novo Nordisk INC | $18.88 | 2024 | Wegovy |
| Shockwave Medical, INC | $17.60 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $16.70 | 2024 | Airsupra |
| Amgen INC. | $16.52 | 2024 | Evenity, Prolia |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $16.07 | 2025 | Cologuard Collection Kit |
| Kiniksa Pharmaceuticals International, Plc | $15.48 | 2024 | Arcalyst |
| Boston Scientific Corporation | $15.15 | 2024 | Watchman Access System |
| Idorsia Pharmaceuticals US INC | $13.78 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Peterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.